We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Clinical Research Management System Improves Study Effectiveness

By LabMedica International staff writers
Posted on 19 Apr 2011
A new clinical research management system (CRMS) will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research-billing compliance. More...


Centricity Research, developed by GE Healthcare (Chalfont St. Giles, UK), a global developer of healthcare information technology (HIT), is the industry's first enterprise-class clinical research management solution. Centricity Research helps institutions conducting clinical or translational research manage the growing complexity of research processes and compliance requirements. Centricity Research has robust functionality, built on the foundation of the currently available Centricity Patient Protocol Management solution, to support both the institutions' and researchers' efforts in achieving compliance, enhancing safety, increasing subject recruitment, and facilitating agency audits.

Moreover, GE Healthcare has developed a strategic partnership with mdlogix (Medical Decision Logic, Inc.; Baltimore, MD, USA), which developed its CRMS in collaboration with the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and other leading clinical research institutions. "The enterprise deployment of CRMS at Johns Hopkins includes all departments in the School of Medicine,” said Dr. Dan Ford, vice-dean of clinical research at the Johns Hopkins School of Medicine. "We have over 4,000 protocols currently in CRMS, with over 1,100 of those being active, and approximately 25% of those protocols using CRMS solely at the discretion of the researchers themselves because of the value they gain from the system. CRMS has helped us more efficiently manage the 30% increase we have achieved in the number of research studies conducted at the Johns Hopkins School of Medicine since 2007.”

Centricity Research helps ensure adherence to protocols and maximizes clinical research dollars, while providing the foundation for the continuous improvement of research processes. The platform can integrate with a variety of existing institutional systems, including electronic institutional review board (IRB) systems, electronic medical record/electronic patient record (EMR/EPR) systems, and revenue cycle management (RCM) systems.

Related Links:

GE Healthcare
mdlogix



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.